Dhanashree Ratra1, Roy Tan2, Durgasri Jaishankar1, Neha Khandelwal2, Arushi Gupta3, Jay Chhablani3, Rupesh Agrawal1,4. 1. Department of Ophthalmology, Medical Research Foundation, Sankara Netralya, Chennai, India. 2. Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Novena, Singapore. 3. Smt Kanuri Santhamma Centre for Vitreoretinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India. 4. School of Material Science and Engineering, Nanyang Technological University, Novena, Singapore.
Abstract
PURPOSE: To evaluate structural changes in the choroid of patients with Stargardt disease using swept source optical coherence tomography scans. METHODS: A retrospective comparison cohort study was conducted on 39 patients with Stargardt disease, and on 25 age and gender matched-healthy controls. Subfoveal choroidal thickness (SFCT) was computed from the swept source optical coherence tomography machine, and the scans were binarized into luminal area and stromal areas, which were then used to derive choroidal vascularity index (CVI). Choroidal vascularity index and SFCT were analyzed independently using linear mixed effects model. RESULTS: There was no significant difference in SFCT between the 2 groups (347.20 ± 13.61 μm in Stargardt disease vs. 333.09 ± 18.96 μm in the control group, P = 0.548). There was a significant decrease in the CVI among eyes with Stargardt disease as compared with the normal eyes (62.51 ± 0.25% vs. 65.45 ± 0.29%, P < 0.001). There was a negative association between visual acuity and CVI (correlation coefficient = -0.75, P < 0.001) and a positive association between visual acuity and SFCT (correlation coefficient = 0.21, P = 0.035). CONCLUSION: Choroidal vascularity index appears to be a more robust tool compared with SFCT for choroidal changes in Stargardt disease. Choroidal vascularity index can possibly be used as a surrogate marker for disease monitoring. A decrease in CVI was associated with a decrease in visual function in eyes with Stargardt disease.
PURPOSE: To evaluate structural changes in the choroid of patients with Stargardt disease using swept source optical coherence tomography scans. METHODS: A retrospective comparison cohort study was conducted on 39 patients with Stargardt disease, and on 25 age and gender matched-healthy controls. Subfoveal choroidal thickness (SFCT) was computed from the swept source optical coherence tomography machine, and the scans were binarized into luminal area and stromal areas, which were then used to derive choroidal vascularity index (CVI). Choroidal vascularity index and SFCT were analyzed independently using linear mixed effects model. RESULTS: There was no significant difference in SFCT between the 2 groups (347.20 ± 13.61 μm in Stargardt disease vs. 333.09 ± 18.96 μm in the control group, P = 0.548). There was a significant decrease in the CVI among eyes with Stargardt disease as compared with the normal eyes (62.51 ± 0.25% vs. 65.45 ± 0.29%, P < 0.001). There was a negative association between visual acuity and CVI (correlation coefficient = -0.75, P < 0.001) and a positive association between visual acuity and SFCT (correlation coefficient = 0.21, P = 0.035). CONCLUSION: Choroidal vascularity index appears to be a more robust tool compared with SFCT for choroidal changes in Stargardt disease. Choroidal vascularity index can possibly be used as a surrogate marker for disease monitoring. A decrease in CVI was associated with a decrease in visual function in eyes with Stargardt disease.
Authors: Talal Alabduljalil; Rachel C Patel; Abdullah A Alqahtani; Simon S Gao; Michael J Gale; Miao Zhang; Yali Jia; David Huang; Pei-Wen Chiang; Rui Chen; Jun Wang; Richard G Weleber; Mark E Pennesi; Paul Yang Journal: Am J Ophthalmol Date: 2019-02-14 Impact factor: 5.258
Authors: Hao Zhou; Yining Dai; Yingying Shi; Jonathan F Russell; Cancan Lyu; Jila Noorikolouri; William J Feuer; Zhongdi Chu; Qinqin Zhang; Luis de Sisternes; Mary K Durbin; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Ophthalmol Retina Date: 2019-10-01
Authors: Hao Zhou; Jie Lu; Kelly Chen; Yingying Shi; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Quant Imaging Med Surg Date: 2022-05
Authors: Mohammed A Rasheed; Niroj K Sahoo; Abhilash Goud; Kiran K Vupparaboina; Jay Chhablani Journal: Indian J Ophthalmol Date: 2018-12 Impact factor: 1.848
Authors: Alessandro Arrigo; Alessio Grazioli; Francesco Romano; Emanuela Aragona; Alessandro Bordato; Carlo di Nunzio; Andrea Sperti; Francesco Bandello; Maurizio Battaglia Parodi Journal: J Clin Med Date: 2019-09-05 Impact factor: 4.241